Complete heart block after infliximab therapy.
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001919:Bradycardia / Q000139:chemically induced; D005260:Female; D006327:Heart Block / Q000139:chemically induced*; D006801:Humans; D000069285:Infliximab; D011239:Prednisolone / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D011239:Prednisolone; D000069285:Infliximab